Metraipolis › archive › dc_722412e13e31

Immunotherapy for Glioblastoma: A Focus on PD-1/PD-L1 Inhibitors — Europe PMC PMID:41374979

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41374979
DOI
10.3390/cancers17233777
License (as archived)
solo-consultazione
Archived
2026-11-08T05:41:42.070Z
SHA-256 of the archived text
308a2501ee3790c9290db668b3de291743c66958235b963c57f60b790dc8c278
Stable URL of this page
https://metraipolis.com/documento/dc_722412e13e31

How to cite

Immunotherapy for Glioblastoma: A Focus on PD-1/PD-L1 Inhibitors — Europe PMC PMID:41374979 — Europe PMC (en), https://europepmc.org/article/MED/41374979 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_722412e13e31 (Metraipolis archive dc_722412e13e31, sha256 308a2501ee3790c9290db668b3de291743c66958235b963c57f60b790dc8c278)
BibTeX
@misc{dc722412e13e31,
  title = {Immunotherapy for Glioblastoma: A Focus on PD-1/PD-L1 Inhibitors — Europe PMC PMID:41374979},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41374979},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_722412e13e31; sha256 308a2501ee3790c9290db668b3de291743c66958235b963c57f60b790dc8c278},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41374979. Agents can read the archived copy with the MCP tool read_document.